drugset / Trial / NCT07020884
A Study of ZT002 Injection With Subjects With Overweight or Obesity
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the percentage change from baseline in weight after 24 weeks of treatment with ZT002 Injection in subjects with overweight/obesity.
Timeline
- Start
- 2024-08-14
- Primary completion
- 2025-05-07
- Completion
- 2025-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZT002 Injection | Unknown | — | Subcutaneous |